505592 — Shreekrishna Biotech Income Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
2014 March 31st | 2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | PRESS | PRESS | PRESS | Interim Report |
Standards: | — | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.323 | 0.083 | 0.043 | 0.178 | 0.045 |
Operating Profit | -0.323 | -0.083 | -0.043 | -0.178 | -0.045 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.048 | -0.083 | -0.043 | -0.178 | -0.045 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.048 | -0.083 | -0.043 | -0.178 | -0.045 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.048 | -0.083 | -0.043 | -0.178 | -0.045 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.048 | -0.083 | -0.043 | -0.178 | -0.045 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.005 | -0.008 | -0.004 | -0.018 | -0.005 |
Dividends per Share |